Search Results
Researcher Spotlight: Dr. Sarah Tasian
Dr Sarah Tasian Discusses Challenges to Overcome When New Therapies Come to Market for Pediatric AML
Dr Sarah Tasian Highlights Challenges With Improving Outcomes in Pediatric AML
Dr Sarah Tasian Highlights Exciting New Advances Coming to Pediatric AML
Clinical responses of pediatric patients with R/R acute leukemia treated with aza/ven
Azacitidine and venetoclax +/- gemtuzumab ozogamicin in pediatric patients with R/R acute leukemias
Dr. Tasian on Challenges in Treating Pediatric Patients With Ph-Like ALL
Areas Under Investigation in Ph-Like ALL
Immunotherapy for pediatric AML
Researcher Spotlight: Conquering Cancer with Dr. Velcheti
An update on targeted therapy in pediatric leukemia
Gilteritinib and CAR T-cell therapy in high-risk pediatric leukemias
